Home Feature Content Type

View the Latest: Feature

Filter

List Grid

111 - 120 of 956 Results

  • Anti-Vaccine Disinformation Campaign, Sunscreen Myths, and Counterfeit Ozempic on Social Media — The Monitor

    Feature

    This edition focuses on intentionally false or misleading information online and its potential impact on public trust in health care. We share a recent report that exposed a covert U.S. military social media disinformation campaign in the Philippines that may have undermined public confidence in vaccines. We also examine how false claims about sunscreen and non-FDA-approved "miracle cures" may be discouraging people from taking important preventative measures and seeking legitimate medical treatment. Finally, we explore the rise of counterfeit diabetes and weight-loss drugs like Ozempic and the potential impact on trust in the pharmaceutical supply chain.

  • Supreme Court Cases on Content Moderation and Mifepristone Access — The Monitor

    Feature

    This issue of the Monitor focuses on recent Supreme Court decisions impacting health misinformation. We examine cases balancing free speech and platform regulation, the Court’s ruling on mifepristone access and public perceptions of social media moderation. We also explore COVID-19 narratives after Dr. Fauci’s congressional testimony and AI developments in predicting misinformation trends during pandemics.

  • KFF Survey of Women Voters Dashboard

    Feature

    The KFF Survey of Women Voters examines differing motivations, attitudes, and experiences among women by race and ethnicity, age, and partisanship heading into the 2024 election nationally and in two battleground states, Arizona and Michigan.

  • Raw Milk Myths, Vaccine Falsehoods, and Reproductive Health Narratives – The Monitor

    Feature

    This first edition of the Health Misinformation Monitor explores misinformation about raw milk amid bird flu outbreaks on dairy farms, false vaccine narratives that continue to spread, and legal challenges against abortion pill reversal claims. Additionally, a growing number of states have required public schools to show fetal development videos that some have called biased and inaccurate. This Monitor report also provides a snapshot of new KFF misinformation polling on TikTok and discusses the early challenges faced by The World Health Organization’s new AI tool SARAH in providing accurate answers to health questions.

  • Global Health Policy Quiz

    Feature

    How much do you know about U.S. efforts to improve health around the world? Take this interactive quiz to find out.

  • Health Policy 101 Introduction

    Feature

    Health Policy 101 is a comprehensive guide covering fundamental aspects of U.S. health policy and programs, including Medicare, Medicaid, the Affordable Care Act, employer-sponsored insurance, the uninsured population, health care costs and affordability, women's health issues, and health care politics. It includes overviews of private health insurance regulation, racial and ethnic disparities, public health, international comparison of health systems, U.S. global health policy, and the federal role in health policy. The chapters can be downloaded in a PDF format for faculty and student use, and the information will be updated annually or as data and circumstances change.

  • KFF Health Tracking Poll May 2024: Voters’ Views of Health Policy Issues in Context of Presidential Campaigns

    Feature

    Voters are split largely along partisan lines in terms of who they trust in regard to various health care issues, but Biden captures more than Trump trust from Independent voters. Biden is also more trusted by older adults when it comes to entitlement programs. Voters are still largely unaware of the drug pricing provisions of the Inflation reduction Act. Large majorities of voters, particularly Democratic voters, support a federal right to abortion.

  • KFF Health Tracking Poll May 2024: The Public’s Use and Views of GLP-1 Drugs

    Feature

    KFF’s latest Health Tracking Poll examines the public’s views and use of an an increasingly popular class of prescription drugs used for weight loss and to treat diabetes or prevent heart attacks or strokes. The poll finds 12% of adults report having taken one of these GLP-1 drugs, which include Ozempic, Webovy and Mounjaro. This includes 6% who say they are currently taking one of the drugs.